GBX2 and gastric cancer: For AOP 410 it was due to the lack of evidence for reduced eye size caused by gbx2 expression inhibition that we moved the development towards the inner ear and the upstream MIE of Gsk3b inactivation, which was also already present in the AOP 298 (entitled Chronic ROS leading to human treatment-resistant gastric cancer).